|
|
||||||||
Faculty of Medicine, Institute of Pharmacology and Therapeutics, 4200 Porto, Portugal
The present
study examined the nature of the apical inward and outward
L-3,4-dihydroxyphenylalanine (L-dopa)
transporters in LLC-PK1 cells and whether protein kinases
differentially modulate the activities of these transporters. The
apical inward transfer of L-dopa was promoted through an
energy-dependent and sodium-insensitive transporter (Michaelis
constant = 38 µM; maximum velocity = 2608 pmol · mg
protein
1 · 6 min
1). This
transporter was insensitive to N-(methylamino)-isobutyric acid but competitively inhibited by
2-aminobicyclo(2,2,1)-heptane-2-carboxylic acid (BHC;
IC50 = 251 µM). Modulators of protein kinase A
(cAMP, forskolin, IBMX, and cholera toxin), protein kinase G (cGMP,
zaprinast, LY-83583 and sodium nitroprusside), and protein kinase C
(phorbol 12,13-dibutirate and chelerythrine) failed to affect the
accumulation of L-dopa. The Ca2+/calmodulin
inhibitors calmidazolium and trifluoperazine inhibited L-dopa uptake (IC50 of 72 and 55 µM,
respectively). The inhibitory effect of calmidazolium on the
accumulation of L-dopa was of the noncompetitive type. The
organic anion inhibitor DIDS, but not p-aminohippurate, and
the protein tyrosine kinase (PTK) inhibitor genistein significantly
increased L-dopa accumulation, which was mainly due to
inhibition of apical outward transfer of L-dopa. It
is concluded that LLC-PK1 cells take up L-dopa
over the apical cell border through the L-type amino acid transporter,
which appears to be under the control of
Ca2+-calmodulin-mediated pathways. The apical outward
transfer of L-dopa may be promoted through a DIDS-sensitive
transport mechanism and appears to be under the tonic control of PTK.
L-3,4-dihydroxyphenylalanine; L-type amino acid transporter; 4,4'-diisothiocynatostilbene-2,2'-disulfonic acid-sensitive transporter; Ca2+/calmodulin; protein tyrosine kinase
This article has been cited by other articles:
![]() |
P. Soares-da-Silva and M. P. Serrao High- and low-affinity transport of L-leucine and L-DOPA by the hetero amino acid exchangers LAT1 and LAT2 in LLC-PK1 renal cells Am J Physiol Renal Physiol, August 1, 2004; 287(2): F252 - F261. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Pinho, P. Gomes, M. P. Serrao, M. J. Bonifacio, and P. Soares-da-Silva Organ-Specific Overexpression of Renal LAT2 and Enhanced Tubular L-DOPA Uptake Precede the Onset of Hypertension Hypertension, October 1, 2003; 42(4): 613 - 618. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chillaron, R. Roca, A. Valencia, A. Zorzano, and M. Palacin Heteromeric amino acid transporters: biochemistry, genetics, and physiology Am J Physiol Renal Physiol, December 1, 2001; 281(6): F995 - F1018. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |